FCGR2A and Thrombocytopenia: However, several adverse side effects, including uncontrolled cytokine release, myelosuppression, blood platelet aggregation, thrombocytopenia and allodynia are linked to unwanted Fc-FcγR ligation or complement activation (9–11).